Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy

Title
Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
Authors
Keywords
-
Journal
JOURNAL OF IMMUNOTHERAPY
Volume 36, Issue 2, Pages 133-151
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2013-01-31
DOI
10.1097/cji.0b013e3182829903

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started